These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 27318203)

  • 1. The structural effects of mutations can aid in differential phenotype prediction of beta-myosin heavy chain (Myosin-7) missense variants.
    Al-Numair NS; Lopes L; Syrris P; Monserrat L; Elliott P; Martin AC
    Bioinformatics; 2016 Oct; 32(19):2947-55. PubMed ID: 27318203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genotype phenotype correlations of cardiac beta-myosin heavy chain mutations in Indian patients with hypertrophic and dilated cardiomyopathy.
    Rai TS; Ahmad S; Bahl A; Ahuja M; Ahluwalia TS; Singh B; Talwar KK; Khullar M
    Mol Cell Biochem; 2009 Jan; 321(1-2):189-96. PubMed ID: 18953637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new common mutation in the cardiac beta-myosin heavy chain gene in Finnish patients with hypertrophic cardiomyopathy.
    Jääskeläinen P; Heliö T; Aalto-Setälä K; Kaartinen M; Ilveskoski E; Hämäläinen L; Melin J; Kärkkäinen S; Peuhkurinen K; Nieminen MS; Laakso M; ; Kuusisto J
    Ann Med; 2014 Sep; 46(6):424-9. PubMed ID: 24888384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-myosin heavy chain: a sarcomeric gene associated with dilated and hypertrophic phenotypes of cardiomyopathy.
    Carniel E; Taylor MR; Sinagra G; Di Lenarda A; Ku L; Fain PR; Boucek MM; Cavanaugh J; Miocic S; Slavov D; Graw SL; Feiger J; Zhu XZ; Dao D; Ferguson DA; Bristow MR; Mestroni L
    Circulation; 2005 Jul; 112(1):54-9. PubMed ID: 15998695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of novel mutations including a double mutation in patients with inherited cardiomyopathy by a targeted sequencing approach using the Ion Torrent PGM system.
    Zhao Y; Cao H; Song Y; Feng Y; Ding X; Pang M; Zhang Y; Zhang H; Ding J; Xia X
    Int J Mol Med; 2016 Jun; 37(6):1511-20. PubMed ID: 27082122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of Phenotypic Differences by Cardiovascular Magnetic Resonance Imaging in MYH7 (β-Myosin Heavy Chain)- Versus MYBPC3 (Myosin-Binding Protein C)-Related Hypertrophic Cardiomyopathy.
    Weissler-Snir A; Hindieh W; Gruner C; Fourey D; Appelbaum E; Rowin E; Care M; Lesser JR; Haas TS; Udelson JE; Manning WJ; Olivotto I; Tomberli B; Maron BJ; Maron MS; Crean AM; Rakowski H; Chan RH
    Circ Cardiovasc Imaging; 2017 Feb; 10(2):. PubMed ID: 28193612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive analysis of the beta-myosin heavy chain gene in 389 unrelated patients with hypertrophic cardiomyopathy.
    Van Driest SL; Jaeger MA; Ommen SR; Will ML; Gersh BJ; Tajik AJ; Ackerman MJ
    J Am Coll Cardiol; 2004 Aug; 44(3):602-10. PubMed ID: 15358028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation of Arg723Gly in beta-myosin heavy chain gene in five Chinese families with hypertrophic cardiomyopathy.
    Yang JH; Zheng DD; Dong NZ; Yang XJ; Song JP; Jiang TB; Cheng XJ; Li HX; Zhou BY; Zhao CM; Jiang WP
    Chin Med J (Engl); 2006 Nov; 119(21):1785-9. PubMed ID: 17097032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A molecular screening strategy based on beta-myosin heavy chain, cardiac myosin binding protein C and troponin T genes in Italian patients with hypertrophic cardiomyopathy.
    Girolami F; Olivotto I; Passerini I; Zachara E; Nistri S; Re F; Fantini S; Baldini K; Torricelli F; Cecchi F
    J Cardiovasc Med (Hagerstown); 2006 Aug; 7(8):601-7. PubMed ID: 16858239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac beta-myosin heavy chain defects in two families with non-compaction cardiomyopathy: linking non-compaction to hypertrophic, restrictive, and dilated cardiomyopathies.
    Hoedemaekers YM; Caliskan K; Majoor-Krakauer D; van de Laar I; Michels M; Witsenburg M; ten Cate FJ; Simoons ML; Dooijes D
    Eur Heart J; 2007 Nov; 28(22):2732-7. PubMed ID: 17947214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered myocyte contractility and calcium homeostasis in alpha-myosin heavy chain point mutations linked to familial dilated cardiomyopathy.
    Klos M; Mundada L; Banerjee I; Morgenstern S; Myers S; Leone M; Kleid M; Herron T; Devaney E
    Arch Biochem Biophys; 2017 Feb; 615():53-60. PubMed ID: 28088328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of cardiac beta-myosin heavy chain gene mutations in patients with hypertrophic cardiomyopathy.
    Perrot A; Schmidt-Traub H; Hoffmann B; Prager M; Bit-Avragim N; Rudenko RI; Usupbaeva DA; Kabaeva Z; Imanov B; Mirrakhimov MM; Dietz R; Wycisk A; Tendera M; Gessner R; Osterziel KJ
    J Mol Med (Berl); 2005 Jun; 83(6):468-77. PubMed ID: 15856146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pediatric restrictive cardiomyopathy associated with a mutation in beta-myosin heavy chain.
    Ware SM; Quinn ME; Ballard ET; Miller E; Uzark K; Spicer RL
    Clin Genet; 2008 Feb; 73(2):165-70. PubMed ID: 18076673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of mutations in symptomatic patients with hypertrophic cardiomyopathy in Taiwan.
    Chiou KR; Chu CT; Charng MJ
    J Cardiol; 2015 Mar; 65(3):250-6. PubMed ID: 25086479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Digenic inheritance of mutations in the cardiac troponin (TNNT2) and cardiac beta myosin heavy chain (MYH7) as the cause of severe dilated cardiomyopathy.
    Petropoulou E; Soltani M; Firoozabadi AD; Namayandeh SM; Crockford J; Maroofian R; Jamshidi Y
    Eur J Med Genet; 2017 Sep; 60(9):485-488. PubMed ID: 28642161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertrophic cardiomyopathy clinical phenotype is independent of gene mutation and mutation dosage.
    Viswanathan SK; Sanders HK; McNamara JW; Jagadeesan A; Jahangir A; Tajik AJ; Sadayappan S
    PLoS One; 2017; 12(11):e0187948. PubMed ID: 29121657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiomyopathy: a systematic review of disease-causing mutations in myosin heavy chain 7 and their phenotypic manifestations.
    Walsh R; Rutland C; Thomas R; Loughna S
    Cardiology; 2010; 115(1):49-60. PubMed ID: 19864899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel correlations between the genotype and the phenotype of hypertrophic and dilated cardiomyopathy: results from the German Competence Network Heart Failure.
    Waldmüller S; Erdmann J; Binner P; Gelbrich G; Pankuweit S; Geier C; Timmermann B; Haremza J; Perrot A; Scheer S; Wachter R; Schulze-Waltrup N; Dermintzoglou A; Schönberger J; Zeh W; Jurmann B; Brodherr T; Börgel J; Farr M; Milting H; Blankenfeldt W; Reinhardt R; Özcelik C; Osterziel KJ; Loeffler M; Maisch B; Regitz-Zagrosek V; Schunkert H; Scheffold T;
    Eur J Heart Fail; 2011 Nov; 13(11):1185-92. PubMed ID: 21750094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted 46-gene and clinical exome sequencing for mutations causing cardiomyopathies.
    Waldmüller S; Schroeder C; Sturm M; Scheffold T; Imbrich K; Junker S; Frische C; Hofbeck M; Bauer P; Bonin M; Gawaz M; Gramlich M
    Mol Cell Probes; 2015 Oct; 29(5):308-14. PubMed ID: 25979592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant hypertrophic cardiomyopathy caused by the Arg723Gly mutation in beta-myosin heavy chain gene.
    Enjuto M; Francino A; Navarro-López F; Viles D; Paré JC; Ballesta AM
    J Mol Cell Cardiol; 2000 Dec; 32(12):2307-13. PubMed ID: 11113006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.